Alzheimer's disease: The new promise

Journal of Clinical Investigation

Volumn 122, Issue 4, 2012, Pages 1191-

  Strittmatter, Warren J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; DONEPEZIL; GALANTAMINE; MEMANTINE; NEUROLEPTIC AGENT; RIVASTIGMINE;

ADULT; AERONAUTICAL SPORT; ALZHEIMER DISEASE; AMNESIA; CASE REPORT; DEPRESSION; FINANCE; HUMAN; IRRITABILITY; JOB PERFORMANCE; MALE; PRIORITY JOURNAL; SHORT SURVEY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MALE; PEPTIDES; VENOMS;

EID: 84859717488     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62745     Document Type: Short Survey

References (7)

1. Maurer K, Volk S, Gerbaldo H. Auguste D and Alzheimer's disease. Lancet. 1997;349(9064):1546-1549. (Pubitemid 27216376)
2. Karran E, Mercken M, DeStrooper B. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. Nat Rev Drug Dis. 2011;10(9):698-712.
3. Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and the right drug at the right stage. Science Trans Med. 2011;3(111):111cm33.⋯̇
4. Talbot K, et al. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest. 2012;122(4):1316-1338.
5. Bomfim TR, et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated A&βετα; oligomers. J Clin Invest. 2012;122(4):1339-1353.
6. DeKroon R, et al. APOE4-VLDL inhibits the HDL-activated phosphtidylinositol3 -kinase/Akt pathway via the phosphoinositol phosphatase SHIP2. Circ Res. 2006;99(8):829-836. (Pubitemid 44556381)
7. Craft S, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment. Arch Neurol. 2012;69(1):29-38.